INTERVIEW · HEALTH · Parker Institute for Cancer Immunotherapy · Milken Global Conference 2025 · 12:08 · Released September 30, 2026
"US cancer mortality has fallen 34% since its 1991 peak." - Milken Global 2025
The CEO of the Parker Institute for Cancer Immunotherapy, formerly head of the American Cancer Society, on personalised mRNA vaccines against recurrence, AI in early detection, and why the average cancer patient sees 32 different providers.
HealthcareAI
Up next
More like this11:19
Technology, Cloud and the Future, GCC Conclave 2019
Ian Khan · GCC Conclave 2019
3:43
Reducing the Friction Between Government and People | Ian Khan at WGS 2024
Government Experience
9:26
Applying 'Never Events' Thinking to Clinical AI | Dr Erin Palm, Infinitus
ViVE 2026
9:04
It Is Impossible to Debank Someone | Dom Kwok, EasyA
Consensus 2025 Toronto
8:32
Ophir Kagan, Co-Founder & CEO of Maitri Health at HLTH2025 with Ian Khan
HLTH 2025
12:38
We Are Automating on Top of Trust We Never Had | Tricia Wang
Consensus 2025 Toronto
7:18
Jenna DiRito, Co-Founder & COO of Revalia Bio at HLTH2025 with Ian Khan
HLTH 2025
9:38
Data Is Oil, and We Like to Be Fracking | Kempton Presley, AdhereHealth
ViVE 2026
11:13
"53% of leaders want more productivity while 80% of workers say they're maxed out." - Milken Global 2025
Microsoft · Milken Global Conference 2025
9:28
American Medicine Is the Best in the World. The System Is Not | Malinka Walaliyadde, AKASA
ViVE 2026